Serial Number | 97407895 |
Word Mark | JIXING |
Filing Date | Thursday, May 12, 2022 |
Status | 686 - PUBLISHED FOR OPPOSITION |
Status Date | Tuesday, September 10, 2024 |
Registration Number | 0000000 |
Registration Date | NOT AVAILABLE |
Mark Drawing | 3 - Illustration: Drawing or design which also includes word(s) / letter(s) / number(s) |
Published for Opposition Date | Tuesday, September 10, 2024 |
Description of Mark | The mark consists of the stylized word "JIXING" in green with the design of a broken heart to the left in color with the left side of the heart being orange and the right side being green with a helix in between the two sides. |
Goods and Services | Pharmaceutical preparations for the treatment of hyperlipidemia; pharmaceutical preparations for the treatment of asthma; cholesterol reducers; antihypertensives; anti-diabetic pharmaceuticals; anti-diabetic preparations; antiarrhythmics; cardiovascular pharmaceutical preparations; pharmaceutical preparation for eye or intraocular surgery; ophthalmic pharmaceutical products; ophthalmic preparations; medical preparations for use with eyes; medicines for the treatment of cardiovascular diseases; pharmaceutical preparations for inhalation for the treatment of pulmonary hypertension; depuratives for the body; medicines for veterinary purposes, namely, veterinary diagnostic reagents, veterinary vaccines, Anti-infective products for veterinary use, and Veterinary preparations, namely, pain relief medication; Enzymes for veterinary purposes; biocides; disinfectant wipes; preparations to facilitate teething; diapers for pets; pharmaceutical candy, namely, medicated candies; medicines for human purposes, namely, human vaccine preparations, Antibiotics for human use, anti-allergic and pain reduction medicines for treatment of illnesses for human purposes; pharmaceutical preparations, namely, pharmaceutical preparations for treatment of human illnesses, namely, heart disease and cancer; chemico-pharmaceutical preparations, namely, chemico-pharmaceutical preparations for treatment of human illnesses, namely, heart disease and cancer; ointments for pharmaceutical purposes, namely, antibiotic, sunburn, anti-inflammatory ointments for pharmaceutical purposes; bronchodilating preparations; injectable pharmaceuticals, namely, injectable pharmaceuticals for treatment of anaphylactic reactions; tablets for pharmaceutical purposes, namely, medicinal preparations for the mouth to be applied in the form of tablets and compressed tablets; tincture of iodine; herbal tinctures for medical purposes; pharmaceutical products for the treatment of infectious diseases; pharmaceutical preparations for the treatment of hypercholesterolemia |
Indication of Colors claimed | The color(s) orange and green is/are claimed as a feature of the mark. |
Goods and Services | Scientific research and development; development of pharmaceutical preparations and medicines; biomedical research services; medical research services; chemical research; biotechnology research; drug testing services; Software as a service (SAAS) services featuring software for analyzing and reporting self-assessment of illness; Software as a service (SAAS) services, namely, hosting software for use by others for use in database management, use as a spreadsheet, word processing; pharmaceutical drug research services; pharmaceutical drug development services |
International Class | 005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides. |
US Class Codes | 005, 006, 018, 044, 046, 051, 052 |
Class Status Code | 6 - Active |
Class Status Date | Tuesday, May 17, 2022 |
Primary Code | 005 |
First Use Anywhere Date | NOT AVAILABLE |
First Use In Commerce Date | NOT AVAILABLE |
International Class | 042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software. |
US Class Codes | 100, 101 |
Class Status Code | 6 - Active |
Class Status Date | Tuesday, May 17, 2022 |
Primary Code | 042 |
First Use Anywhere Date | NOT AVAILABLE |
First Use In Commerce Date | NOT AVAILABLE |
Party Name | Ji Xing Pharmaceuticals (Shanghai) Co., Ltd. |
Party Type | 20 - Owner at Publication |
Legal Entity Type | 03 - Corporation |
Address | Shanghai 200040 CN |
Party Name | Ji Xing Pharmaceuticals (Shanghai) Co., Ltd. |
Party Type | 10 - Original Applicant |
Legal Entity Type | 03 - Corporation |
Address | Shanghai 200040 CN |
Event Date | Event Description |
Wednesday, May 18, 2022 | NOTICE OF DESIGN SEARCH CODE E-MAILED |
Monday, May 16, 2022 | NEW APPLICATION ENTERED |
Tuesday, May 17, 2022 | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED |
Monday, May 30, 2022 | ASSIGNED TO EXAMINER |
Tuesday, May 31, 2022 | NON-FINAL ACTION WRITTEN |
Tuesday, May 31, 2022 | NON-FINAL ACTION E-MAILED |
Tuesday, May 31, 2022 | NOTIFICATION OF NON-FINAL ACTION E-MAILED |
Tuesday, November 29, 2022 | TEAS RESPONSE TO OFFICE ACTION RECEIVED |
Tuesday, November 29, 2022 | CORRESPONDENCE RECEIVED IN LAW OFFICE |
Tuesday, November 29, 2022 | TEAS/EMAIL CORRESPONDENCE ENTERED |
Wednesday, November 30, 2022 | SUSPENSION LETTER WRITTEN |
Wednesday, November 30, 2022 | LETTER OF SUSPENSION E-MAILED |
Wednesday, November 30, 2022 | NOTIFICATION OF LETTER OF SUSPENSION E-MAILED |
Thursday, June 8, 2023 | SUSPENSION INQUIRY WRITTEN |
Thursday, June 8, 2023 | INQUIRY TO SUSPENSION E-MAILED |
Thursday, June 8, 2023 | NOTIFICATION OF INQUIRY AS TO SUSPENSION E-MAILED |
Wednesday, August 30, 2023 | TEAS RESPONSE TO SUSPENSION INQUIRY RECEIVED |
Monday, January 22, 2024 | ASSIGNED TO LIE |
Monday, January 22, 2024 | CORRESPONDENCE RECEIVED IN LAW OFFICE |
Monday, January 22, 2024 | TEAS/EMAIL CORRESPONDENCE ENTERED |
Monday, January 22, 2024 | SUSPENSION LETTER WRITTEN |
Monday, January 22, 2024 | LETTER OF SUSPENSION E-MAILED |
Monday, January 22, 2024 | NOTIFICATION OF LETTER OF SUSPENSION E-MAILED |
Friday, August 2, 2024 | TEAS RESPONSE TO SUSPENSION INQUIRY RECEIVED |
Sunday, August 4, 2024 | TEAS/EMAIL CORRESPONDENCE ENTERED |
Tuesday, August 6, 2024 | APPROVED FOR PUB - PRINCIPAL REGISTER |
Wednesday, August 21, 2024 | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED |
Tuesday, September 10, 2024 | PUBLISHED FOR OPPOSITION |
Tuesday, September 10, 2024 | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED |
Sunday, August 4, 2024 | CORRESPONDENCE RECEIVED IN LAW OFFICE |